In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

ITM announces positive Phase 3 results for ITM-11 in neuroendocrine tumours, paving the way for a potential new treatment ...

The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce Professor Ashley Grossman, F.Med.Sci., as the winner of the 2025 Transatlantic Alliance Award.

MAHTAB SOHREVARDI ENDOCRINOLOGY Physician Huntington Health Dr. Mahtab Sohrevardi’s area of interest is thyroidal disorders ...

Aaron Rejino and loyal Rejino Barbeque customers mourned the loss of Christina Rejino. The co-owner passed away on Jan. 14 ...

Patients on the firm's SSTR-targeted radiopharmaceutical had improved progression-free survival compared to patients on an mTor inhibitor in a Phase III trial.

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Discover ITM and its cancer candidate ITM-11 as it brings one of the first big wins the radiopharmaceutical sector awaits.